Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

255.00
+4.091.63%
Post-market: 255.810.8100+0.32%19:57 EDT
Volume:4.40M
Turnover:1.12B
Market Cap:450.68B
PE:72.04
High:255.31
Open:251.23
Low:249.74
Close:250.91
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.03
T/O Rate:0.25%
Dividend:6.83
Dividend Rate:2.68%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-75.94
PE(LYR):108.05

Loading ...

AbbVie Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 04

AbbVie’s ABBV-706 Lung Cancer Trial: A New Late-Stage Bet in Small Cell Oncology

TIPRANKS
·
Aug 04

AbbVie’s RAMpUp Study Targets Real-World Edge in Atopic Dermatitis

TIPRANKS
·
Aug 04

AbbVie Pipeline Draws Greater Investor Focus After 'Strong' Q2, RBC Says

MT Newswires Live
·
Aug 03

AbbVie is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 03

Canaccord Genuity Adjusts AbbVie Price Target to $290 From $282, Maintains Buy Rating

MT Newswires Live
·
Aug 03

AbbVie price target raised to $285 from $265 at Cantor Fitzgerald

TIPRANKS
·
Aug 03

Street View: Strength in AbbVie's Immunology Pipeline to Support Revenue Growth

Reuters
·
Aug 03

Krystal Biotech Q2 Revenue Rises on Vyjuvek Strength

Reuters
·
Aug 03

Integer Holdings Q2 Sales Fall 2.6%; KKR to Buy Company for $5.7 Billion

Reuters
·
Aug 03

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

Reuters
·
Aug 03

China's WuXi AppTec H1 Revenue Rises, Raises 2026 Guidance

Reuters
·
Aug 03

U.S. Research Roundup-Abbvie, Amazon, Illumina

Reuters
·
Aug 03

JPMorgan Adjusts Price Target on AbbVie to $285 From $280

MT Newswires Live
·
Aug 01

Abbvie Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), AbbVie (ABBV) and Cencora (COR)

TIPRANKS
·
Aug 01

AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock is Falling.

Dow Jones
·
Aug 01

Sector Update: Healthcare

MT Newswires Live
·
Aug 01

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

TIPRANKS
·
Aug 01

AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline

TIPRANKS
·
Aug 01